Are you currently at the 58th #EUROTOX? Don’t miss Tuesday’s lunchtime session “Cross-industry Learnings: Regulatory Safety Assessment Testing and NAMs Supporting the 3Rs”, where our experts Ilse Tonk and Sarah Gould will lead an interactive discussion on the application of alternatives in safety testing across industries to advance the 3Rs. https://okt.to/YlweGs #EUROTOX2024
Charles River Laboratories
Biotechnology Research
Wilmington, Massachusetts 191,385 followers
Together, We Create Healthier Lives
About us
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
- Website
-
http://criver.com
External link for Charles River Laboratories
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Wilmington, Massachusetts
- Type
- Public Company
- Founded
- 1947
- Specialties
- Research Models & Services, Preclinical Services, Discovery Research Services, Biologics Testing Solutions, Microbial Identificiation, Endotoxin Testing, LAL, Early Discovery, Safety Testing, and Agrochemical
Locations
-
Primary
251 Ballardvale Street
Wilmington, Massachusetts 01887, US
Employees at Charles River Laboratories
-
Tracy Vachon
-
Michelle Berthiaume
Senior Director Global Change Management at Charles River Laboratories
-
Nick Hong
Associate Director, Global Categories Procurement at Charles River Laboratories
-
Tim DiMacchia, MBA
A results-oriented executive with a proven track record in driving technological excellence and innovation.
Updates
-
Whether you’re in the early stages or near commercialization, it’s important to understand HEK293 cells’ potential for CGTs and what you need to consider when banking them. Register for our webinar on September 17 to learn more: https://okt.to/WV3qu9 Tuesday, September 17, 2024 11:00 AM EDT | 5:00 PM CEST | Duration 1 Hour
-
Screening #agrochemical compounds with high sensitization potential may seem complex. In this webinar, our expert discusses an approach effective approach to minimize risk in your agrochemical development. https://okt.to/qdWPtM
-
Save your seat for the 2024 European Cell & Gene Therapy Summit, October 15, in London: https://okt.to/UISVTs - Learn how to overcome adversity with Prof. Alejandro Madrigal Fernandez, OBE, UCL - Get the latest regulatory insights from Dr. Alison Niewiarowska, Medicines and Healthcare products Regulatory Agency - Hear the patient’s story from Lucy Ellerker-Jones, parent and founder, Opie Jones Foundation And much more. View the full agenda and register today! https://okt.to/ikGM1T #CGTSummit #cellandgenetherapy #advancedtherapies #concepttocure
-
Don’t miss us at the 58th #EUROTOX. Learn how our services and initiatives such as virtual control groups (VCGs), endocrine disruption solutions, and more, fit within this year’s theme of “A Quest for safe Chemicals and Medicines.” Schedule a meeting and view our list of presentations here: https://okt.to/gwJKpz #EUROTOX2024
-
Join Matthew Hewitt's presentation, “Fast technology coupled with deliberate regulatory: How can the field adapt new guidance to meet therapeutic demand?” CAR-TCR Summit Series As the number of CGT market approvals accelerates, Matt will discuss challenges in manufacturing and address how working collaboratively with partners and regulators aids in tackling the pain points of therapeutic development and clinical trial design. Don't miss this insightful session on regulatory guidance. https://okt.to/KTZMwk #cartcr #cgtdevelopment #celltherapy
-
There are only two weeks left to sign up for our September 19 webinar in conjunction with SpringerNature, titled “Gene Therapy Research: Pitfalls and Best Practices” featuring a live Q&A session with gene therapy experts from Affinia Therapeutics and Gates Biomanufacturing Facility. https://okt.to/rqWUtB
-
Ready to take your preclinical research to the next level? At Charles River Laboratories, we provide researchers with the highest quality research models, turnkey vivarium solutions, and comprehensive diagnostic services to accelerate your scientific discoveries. Whether you're in need of genetically engineered models, preclinical services, or consulting expertise, Charles River has the resources to support your research every step of the way. Discover how our innovative solutions can help you achieve your research goals faster and with greater accuracy. Partner with us to push the boundaries of science and make meaningful impacts in the world of health and medicine https://okt.to/FJcGDR * Humanized models are only available in NA
-
Dr. Kacey Ronaldson-Bouchard from Columbia University, who is an expert on linking #organs on a chip together to form models of human systems joins our Sounds of Science #podcast. Can these models replace animals? Can they save time and money in drug development and safety testing? Find out now when you listen to this podcast! https://okt.to/a2GPHE
-
Hear from Kate Voss, Associate Directory of Toxicology at our Kansas site, about how the unique blend of speed, quality, and flexibility delivers exceptional value offered and empowers you to accelerate drug development and get your compounds to market faster. https://okt.to/mR2ylf #drugdevelopment #toxicology #Kansas